Qube Research & Technologies LTD Rx Sight, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Rx Sight, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 386,210 shares of RXST stock, worth $3.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
386,210
Previous 323,023
19.56%
Holding current value
$3.29 Million
Previous $8.16 Million
38.45%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding RXST
# of Institutions
182Shares Held
35.9MCall Options Held
42.2KPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA3.7MShares$31.5 Million1.05% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$19.4 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$15 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.32MShares$11.2 Million0.01% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $235M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...